Clinical Trials Logo

Other Surgical Procedures clinical trials

View clinical trials related to Other Surgical Procedures.

Filter by:

NCT ID: NCT01580176 Completed - Clinical trials for Other Surgical Procedures

Continuous GlucoseMonitor for Measurement of Blood Glucose Level

ContAssGlu
Start date: March 2012
Phase: N/A
Study type: Interventional

This study will be the first study in which the new central venous microdialysis-based continuous glucose monitoring system (Continuous GlucoseMonitor) is used to investigate the performance of this Continuous GlucoseMonitor, as the measurements will be compared with a point of care reference (RAPIDLab® 1265 blood gas analyser). Further important points are also much less blood samplings / blood loss for the patient and personnel costs.

NCT ID: NCT01433029 Completed - Clinical trials for Other Surgical Procedures

Objective Assessment of Technical Skills in Cardiothoracic Surgery

Start date: September 1, 2011
Phase: N/A
Study type: Observational

The goal of this research study is to develop a method of rating videos of CAB procedures that will produce a reliable assessment of a cardiothoracic surgical trainee's technical proficiency. In addition, researchers also want to learn if using a video manual to train raters can help improve rater reliability.

NCT ID: NCT01309360 Completed - Clinical trials for Other Surgical Procedures

Ultrasound-guided Axillary Plexus Block - Dose Reduction of Prilocaine

Start date: September 2009
Phase: Phase 4
Study type: Interventional

Clinical aim: Does reducing the dose of local anesthetic in ultrasound-guided axillary plexus anesthesia have any effect on the success rate and additional parameters of block quality? Methodology: In this prospective cohort study three groups of 40 outpatients each were administered dosages of 1% prilocaine of either 40mL, 30mL or 20mL for axillary plexus anesthesia. Met-Hb was measured prior to administration of the block and then hourly until the Met-Hb concentration fell. Parameters of block quality and any adverse effects were recorded. The level of significance was defined with α ≤ 0.05.